Millendo Therapeutics US, Inc.
3 clinical trials · Sponsor
◉ Watch Millendo Therapeutics US, Inc.
| Record | Firm | Date |
|---|---|---|
| Nevanimibe HCl for the Treatment of Classic CAH (NCT03669549) | Millendo Therapeutics US, Inc. | 2018-07-11 |
| A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome (NCT03053271) | Millendo Therapeutics US, Inc. | 2017-04-13 |
| MLE4901 vs. Placebo for the Treatment of PCOS (NCT02865915) | Millendo Therapeutics US, Inc. | 2016-07-01 |
Track Millendo Therapeutics US, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.